Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves the survival of gastric cancer patients with ovarian metastasis and peritoneal dissemination
β Scribed by Wu, Xiao-Jiang; Yuan, Peng; Li, Zi-Yu; Bu, Zhao-De; Zhang, Lian-Hai; Wu, Ai-Wen; Zong, Xiang-Long; Li, Shuang-Xi; Shan, Fei; Ji, Xin; Ren, Hui; Ji, Jia-Fu
- Book ID
- 118302919
- Publisher
- S. Karger AG
- Year
- 2012
- Tongue
- English
- Weight
- 149 KB
- Volume
- 34
- Category
- Article
- ISSN
- 1010-4283
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Background The prognosis for gastric cancer patients with peritoneal dissemination is very poor. The purpose of this study was to evaluate the survival benefit from gastrectomy with hyperthermic intraperitoneal chemotherapy (HIPEC) for gastric cancer patients with peritoneal dissemi
## Background This randomized phase III study was to evaluate the efficacy and safety of cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) for the treatment of peritoneal carcinomatosis (PC) from gastric cancer. ## Methods Sixty-eight gastric PC patients were rand